Down-Regulation of lncRNA CKMT2-AS1 Predicts Poor Prognosis and Promotes Breast Cancer Progression. Xue D, Hou R, Xu H, Li X, et al. Breast Cancer (Dove Med Press) 2025;17:1397-1411.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xue D, Hou R, Xu H, Li X, et al. Down-Regulation of lncRNA CKMT2-AS1 Predicts Poor Prognosis and Promotes Breast Cancer Progression. Breast Cancer (Dove Med Press) 2025;17:1397-1411.
PMID: 41476673